Amitiza and Pataday drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Amitiza (lubiprostone) and Pataday (olopatadine hydrochloride). Common drug interactions include peripheral swelling among females and gastroenteritis viral among males.

The phase IV clinical study analyzes what interactions people have when they take Amitiza and Pataday. It is created by eHealthMe based on reports of 40 people who take the same drugs from the FDA, and is updated regularly.

What is Amitiza?

Amitiza has active ingredients of lubiprostone. It is often used in constipation. eHealthMe is studying from 10,567 Amitiza users. Check the latest studies of Amitiza.

What is Pataday?

Pataday has active ingredients of olopatadine hydrochloride. It is often used in allergies. eHealthMe is studying from 8,288 Pataday users. Check the latest studies of Pataday.



On Aug, 13, 2026

40 people who take Amitiza and Pataday together, and have interactions are studied.

Amitiza and Pataday drug interactions.

What are the common drug interactions of Amitiza and Pataday, by gender? *:

female:

  1. Peripheral swelling
  2. Plantar fasciitis (painful inflammatory process of the plantar fascia)
  3. Rash
  4. Renal injury (kidney injury)
  5. Rotator cuff syndrome (a spectrum of conditions affecting the rotator cuff tendons of the shoulder)
  6. Sinus disorder (disease of sinus)
  7. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  8. Surgery
  9. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  10. Uterine prolapse

male:

  1. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  2. Pain
  3. Aphasia (damage to the parts of the brain that control language)
  4. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  5. Asthenia (weakness)
  6. Asthenopia (eyestrain-tiredness of the eyes caused by prolonged close work by a person with an uncorrected vision problem)
  7. Back pain
  8. Balance disorder
  9. Bone density decreased
  10. Chronic kidney disease

What are the common drug interactions of Amitiza and Pataday, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Pain
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Anxiety
  4. Bone density decreased
  5. Chronic kidney disease
  6. Depressed mood
  7. Emotional distress
  8. Irritability
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Weight increased

40-49:

  1. Chronic kidney disease
  2. Alopecia (absence of hair from areas of the body)
  3. Bladder prolapse (bulging of one or more of the pelvic organs into the vagina)
  4. Dizziness
  5. Fatigue (feeling of tiredness)
  6. Feeling jittery
  7. Limb injury
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Migraine (headache)
  10. Nasopharyngitis (inflammation of the nasopharynx)

50-59:

  1. Tendon rupture (tear of tendon)
  2. Headache (pain in head)
  3. Weight increased
  4. Pruritus (severe itching of the skin)
  5. Pruritus generalised (generalized itching)
  6. Alopecia (absence of hair from areas of the body)
  7. Arthralgia (joint pain)
  8. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  9. Decreased appetite
  10. Pain

60+:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Alopecia (absence of hair from areas of the body)
  4. Aphasia (damage to the parts of the brain that control language)
  5. Arthralgia (joint pain)
  6. Asthenia (weakness)
  7. Asthenopia (eyestrain-tiredness of the eyes caused by prolonged close work by a person with an uncorrected vision problem)
  8. Back pain
  9. Balance disorder
  10. Cellulitis (infection under the skin)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 13 people, 32.50%
  2. Pain: 12 people, 30.00%
  3. High Blood Pressure: 11 people, 27.50%
  4. Hypersensitivity: 10 people, 25.00%
  5. Stress And Anxiety: 10 people, 25.00%
  6. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 10 people, 25.00%
  7. Asthma: 9 people, 22.50%
  8. Infection: 9 people, 22.50%
  9. Depression: 9 people, 22.50%
  10. High Blood Cholesterol: 8 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Amitiza and Pataday?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Amitiza and Pataday:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Amitiza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Pataday:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Amitiza and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pataday and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lubiprostone and olopatadine hydrochloride (the active ingredients of Amitiza and Pataday, respectively), and Amitiza and Pataday (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: